transcatheter valve-in-valve procedure
Jump to navigation
Jump to search
Indications
- Sapien 3 artificial heart valve FDA-approved for transcatheter valve-in-valve procedure for patients whose bioprosthetic aortic or mitral valves have failed[1]
More general terms
Additional terms
References
- ↑ Jump up to: 1.0 1.1 FDA News Release. June 5, 2017 FDA expands use of Sapien 3 artificial heart valve for high- risk patients. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm561924.htm
- ↑ Davidson LJ, Davidson CJ Transcatheter Treatment of Valvular Heart Disease. A Review. JAMA. 2021;325(24):2480-2494 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34156404 https://jamanetwork.com/journals/jama/fullarticle/2781245